Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia

Primary induction failure (PIF) in patients with acute myeloid leukemia (AML) is defined by the persistence of more than 5% of blasts [1] after 1–2 cycles of intensive chemotherapy (ICT) [1,2]. PIF...